Association of serum adipocyte fatty acid-binding protein and apolipoprotein B /apolipoprotein A1 ratio with intima media thickness of common carotid artery in dyslipidemic patients
Language English Country Czech Republic Media print-electronic
Document type Journal Article
PubMed
30209438
DOI
10.5507/bp.2018.043
Knihovny.cz E-resources
- Keywords
- adipocyte fatty acid binding protein, dyslipidemia, intima media thickness,
- MeSH
- Apolipoprotein A-I blood MeSH
- Apolipoprotein B-100 blood MeSH
- Carotid Artery, Common diagnostic imaging MeSH
- Atherosclerosis blood diagnostic imaging MeSH
- Adult MeSH
- Dyslipidemias blood diagnostic imaging MeSH
- Carotid Intima-Media Thickness MeSH
- Insulin Resistance MeSH
- Middle Aged MeSH
- Humans MeSH
- Metabolic Syndrome blood diagnostic imaging MeSH
- Carotid Artery Diseases blood diagnostic imaging MeSH
- Fatty Acid-Binding Proteins blood MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- APOA1 protein, human MeSH Browser
- APOB protein, human MeSH Browser
- Apolipoprotein A-I MeSH
- Apolipoprotein B-100 MeSH
- FABP4 protein, human MeSH Browser
- Fatty Acid-Binding Proteins MeSH
BACKGROUND: Diseases caused by atherosclerosis play the most important role in mortality and morbidity worldwide. Serum adipocyte fatty acid binding protein (A-FABP) seems to be a new promising marker to determine the risk of atherosclerosis. OBJECTIVE: The aim of this study was to evaluate relationships between serum A-FABP levels in studied individuals and to assess the possibility of modeling the intima media thickness of the common carotid artery (C-IMT) using A-FABP levels and other observed characteristics. METHODS: Seventy two Caucasian individuals were enrolled and divided into 3 groups: dyslipidemic patients with or without metabolic syndrome (MetS+, n=17; MetS-, n= 34) and controls (n=21). RESULTS: There was confirmed the well-established risk profile of individuals with MetS (unfavorable lipid and lipoprotein profile, as well as increased parameters of insulin resistence and C-IMT). A-FABP concentrations in this group were significantly higher in comparison with both MetS- and controls. CONCLUSION: Using multiple linear regression models of C-IMT values for all individual data, healthy controls and dyslipidemic patients without metabolic syndrome (MetS-) A-FABP levels were not revealed as an important predictor of C-IMT in our model. In contrast, age, gender, waist circumference, nonHDL cholesterol levels and ApoB/ApoA1 ratio were important repressors of C- IMT in study individuals. This finding may be attributed to the overwhelming effect of other more robust risk factors for atherosclerosis in these individuals.
References provided by Crossref.org